{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:56:59Z","timestamp":1790128619452,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81601041"],"award-info":[{"award-number":["81601041"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870831"],"award-info":[{"award-number":["81870831"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rolipram specifically inhibits phosphodiesterase (PDE) 4, thereby preventing inactivation of the intracellular second messenger cyclic adenosine monophosphate (cAMP). Rolipram has been shown to play a neuroprotective role in some central nervous system (CNS) diseases. However, the role of PDE4 and the potential protective effect of rolipram on the pathophysiological process of intracerebral haemorrhage (ICH) are still not entirely clear. In this study, a mouse model of ICH was established by the collagenase method. Rolipram reduced brain oedema, blood\u2013brain barrier (BBB) leakage, neuronal apoptosis and inflammatory cytokine release and improved neurological function in our mouse model of ICH. Moreover, rolipram increased the levels of cAMP and silent information regulator 1 (SIRT1) and upregulated the phosphorylation of AMP-activated protein kinase (AMPK). Furthermore, these effects of rolipram could be reversed by the SIRT1 inhibitor sirtinol. In conclusion, rolipram can play a neuroprotective role in the pathological process of ICH by activating the cAMP\/AMPK\/SIRT1 pathway.<\/jats:p>","DOI":"10.1038\/s41598-021-98743-w","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T13:52:53Z","timestamp":1633441973000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The protective effect of the PDE-4 inhibitor rolipram on intracerebral haemorrhage is associated with the cAMP\/AMPK\/SIRT1 pathway"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiao-Liu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"98743_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2018.05.003","volume":"163\u2013164","author":"G Chen","year":"2018","unstructured":"Chen, G., Leak, R. K., Sun, Q., Zhang, J. H. & Chen, J. Neurobiology of stroke: Research progress and perspectives. Prog. Neurobiol. 163\u2013164, 1\u20134. https:\/\/doi.org\/10.1016\/j.pneurobio.2018.05.003 (2018).","journal-title":"Prog. Neurobiol."},{"key":"98743_CR2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semcdb.2018.12.003","volume":"95","author":"BL Marques","year":"2019","unstructured":"Marques, B. L. et al. The role of neurogenesis in neurorepair after ischemic stroke. Semin Cell Dev. Biol. 95, 98\u2013110. https:\/\/doi.org\/10.1016\/j.semcdb.2018.12.003 (2019).","journal-title":"Semin Cell Dev. Biol."},{"key":"98743_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0140-6736(18)31269-8","volume":"392","author":"JD Pandian","year":"2018","unstructured":"Pandian, J. D. et al. Prevention of stroke: A global perspective. Lancet 392, 1269\u20131278. https:\/\/doi.org\/10.1016\/S0140-6736(18)31269-8 (2018).","journal-title":"Lancet"},{"key":"98743_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1474-4422(12)70104-7","volume":"11","author":"RF Keep","year":"2012","unstructured":"Keep, R. F., Hua, Y. & Xi, G. Intracerebral haemorrhage: Mechanisms of injury and therapeutic targets. Lancet Neurol. 11, 720\u2013731. https:\/\/doi.org\/10.1016\/S1474-4422(12)70104-7 (2012).","journal-title":"Lancet Neurol."},{"key":"98743_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000445170","volume":"42","author":"H Zheng","year":"2016","unstructured":"Zheng, H., Chen, C., Zhang, J. & Hu, Z. Mechanism and therapy of brain edema after intracerebral hemorrhage. Cerebrovasc. Dis. 42, 155\u2013169. https:\/\/doi.org\/10.1159\/000445170 (2016).","journal-title":"Cerebrovasc. Dis."},{"key":"98743_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1177\/0271678X18805675","volume":"39","author":"X Lan","year":"2019","unstructured":"Lan, X., Han, X., Liu, X. & Wang, J. Inflammatory responses after intracerebral hemorrhage: From cellular function to therapeutic targets. J. Cereb. Blood Flow Metab. 39, 184\u2013186. https:\/\/doi.org\/10.1177\/0271678X18805675 (2019).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"98743_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jnr.24372","volume":"98","author":"M Selim","year":"2020","unstructured":"Selim, M. & Norton, C. Perihematomal edema: Implications for intracerebral hemorrhage research and therapeutic advances. J. Neurosci. Res. 98, 212\u2013218. https:\/\/doi.org\/10.1002\/jnr.24372 (2020).","journal-title":"J. Neurosci. Res."},{"key":"98743_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/jmri.25540","volume":"46","author":"SM Wong","year":"2017","unstructured":"Wong, S. M. et al. Measuring subtle leakage of the blood-brain barrier in cerebrovascular disease with DCE-MRI: Test\u2013retest reproducibility and its influencing factors. J. Magn. Reson. Imaging 46, 159\u2013166. https:\/\/doi.org\/10.1002\/jmri.25540 (2017).","journal-title":"J. Magn. Reson. Imaging"},{"key":"98743_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ana.24891","volume":"81","author":"MJ Lee","year":"2017","unstructured":"Lee, M. J. et al. Blood-brain barrier breakdown in reversible cerebral vasoconstriction syndrome: Implications for pathophysiology and diagnosis. Ann. Neurol. 81, 454\u2013466. https:\/\/doi.org\/10.1002\/ana.24891 (2017).","journal-title":"Ann. Neurol."},{"key":"98743_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-3-319-58811-7_7","volume":"17","author":"RT Hansen 3rd","year":"2017","unstructured":"Hansen, R. T. 3rd. & Zhang, H. T. The past, present, and future of phosphodiesterase-4 modulation for age-induced memory loss. Adv. Neurobiol. 17, 169\u2013199. https:\/\/doi.org\/10.1007\/978-3-319-58811-7_7 (2017).","journal-title":"Adv. Neurobiol."},{"key":"98743_CR11","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1517\/13543776.2014.968127","volume":"24","author":"A Martinez","year":"2014","unstructured":"Martinez, A. & Gil, C. cAMP-specific phosphodiesterase inhibitors: Promising drugs for inflammatory and neurological diseases. Expert Opin. Ther. Pat. 24, 1311\u20131321. https:\/\/doi.org\/10.1517\/13543776.2014.968127 (2014).","journal-title":"Expert Opin. Ther. Pat."},{"key":"98743_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1517\/13543776.2013.794789","volume":"23","author":"A Gavalda","year":"2013","unstructured":"Gavalda, A. & Roberts, R. S. Phosphodiesterase-4 inhibitors: A review of current developments (2010\u20132012). Expert Opin. Ther. Pat. 23, 997\u20131016. https:\/\/doi.org\/10.1517\/13543776.2013.794789 (2013).","journal-title":"Expert Opin. Ther. Pat."},{"key":"98743_CR13","first-page":"835","volume":"17","author":"C Pincelli","year":"2018","unstructured":"Pincelli, C., Schafer, P. H., French, L. E., Augustin, M. & Krueger, J. G. Mechanisms underlying the clinical effects of apremilast for psoriasis. J. Drugs Dermatol. 17, 835\u2013840 (2018).","journal-title":"J. Drugs Dermatol."},{"key":"98743_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.biopha.2018.01.093","volume":"99","author":"Q Li","year":"2018","unstructured":"Li, Q. et al. Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1\/Akt pathway. Biomed. Pharmacother. 99, 947\u2013955. https:\/\/doi.org\/10.1016\/j.biopha.2018.01.093 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"98743_CR15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11064-018-2480-4","volume":"43","author":"Y Peng","year":"2018","unstructured":"Peng, Y. et al. Rolipram attenuates early brain injury following experimental subarachnoid hemorrhage in rats: Possibly via regulating the SIRT1\/NF-kappaB Pathway. Neurochem. Res. 43, 785\u2013795. https:\/\/doi.org\/10.1007\/s11064-018-2480-4 (2018).","journal-title":"Neurochem. Res."},{"key":"98743_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.4161\/adip.21158","volume":"1","author":"JH Chung","year":"2012","unstructured":"Chung, J. H. Metabolic benefits of inhibiting cAMP-PDEs with resveratrol. Adipocyte 1, 256\u2013258. https:\/\/doi.org\/10.4161\/adip.21158 (2012).","journal-title":"Adipocyte"},{"key":"98743_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","volume":"11","author":"C Canto","year":"2010","unstructured":"Canto, C. et al. Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11, 213\u2013219. https:\/\/doi.org\/10.1016\/j.cmet.2010.02.006 (2010).","journal-title":"Cell Metab."},{"key":"98743_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12868-017-0364-1","volume":"18","author":"P Singh","year":"2017","unstructured":"Singh, P., Hanson, P. S. & Morris, C. M. SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson\u2019s disease. BMC Neurosci. 18, 46. https:\/\/doi.org\/10.1186\/s12868-017-0364-1 (2017).","journal-title":"BMC Neurosci."},{"key":"98743_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.brainresbull.2016.02.011","volume":"121","author":"D Wan","year":"2016","unstructured":"Wan, D. et al. Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP\/AMPK\/SIRT1 pathway after stroke in rats. Brain Res. Bull. 121, 255\u2013262. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.02.011 (2016).","journal-title":"Brain Res. Bull."},{"key":"98743_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20021698","volume":"370","author":"MD Houslay","year":"2003","unstructured":"Houslay, M. D. & Adams, D. R. PDE4 cAMP phosphodiesterases: Modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J. 370, 1\u201318. https:\/\/doi.org\/10.1042\/BJ20021698 (2003).","journal-title":"Biochem. J."},{"key":"98743_CR21","doi-asserted-by":"publisher","first-page":"F576","DOI":"10.1152\/ajprenal.00477.2019","volume":"318","author":"M Xu","year":"2020","unstructured":"Xu, M. et al. Inhibition of PDE4\/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 318, F576\u2013F588. https:\/\/doi.org\/10.1152\/ajprenal.00477.2019 (2020).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"98743_CR22","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/cvr\/cvy161","volume":"115","author":"S Idres","year":"2019","unstructured":"Idres, S. et al. Contribution of BKCa channels to vascular tone regulation by PDE3 and PDE4 is lost in heart failure. Cardiovasc. Res. 115, 130\u2013144. https:\/\/doi.org\/10.1093\/cvr\/cvy161 (2019).","journal-title":"Cardiovasc. Res."},{"key":"98743_CR23","doi-asserted-by":"publisher","first-page":"L507","DOI":"10.1152\/ajplung.00069.2017","volume":"313","author":"LEM Kistemaker","year":"2017","unstructured":"Kistemaker, L. E. M. et al. The PDE4 inhibitor CHF-6001 and LAMAs inhibit bronchoconstriction-induced remodeling in lung slices. Am. J. Physiol. Lung Cell Mol. Physiol. 313, L507\u2013L515. https:\/\/doi.org\/10.1152\/ajplung.00069.2017 (2017).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"98743_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bcp.2019.02.023","volume":"163","author":"B Xu","year":"2019","unstructured":"Xu, B. et al. FCPR03, a novel phosphodiesterase 4 inhibitor, alleviates cerebral ischemia\/reperfusion injury through activation of the AKT\/GSK3beta\/beta-catenin signaling pathway. Biochem. Pharmacol. 163, 234\u2013249. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.023 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"98743_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1124\/jpet.106.106096","volume":"319","author":"CS Moore","year":"2006","unstructured":"Moore, C. S. et al. Peripheral phosphodiesterase 4 inhibition produced by 4-[2-(3,4-Bis-difluoromethoxyphenyl)-2-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan -2-yl)-phenyl]-ethyl]-3-methylpyridine-1-oxide (L-826,141) prevents experimental autoimmune encephalomyelitis. J. Pharmacol. Exp. Ther. 319, 63\u201372. https:\/\/doi.org\/10.1124\/jpet.106.106096 (2006).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"98743_CR26","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.biopha.2017.01.059","volume":"88","author":"A Kumar","year":"2017","unstructured":"Kumar, A. & Singh, N. Inhibitor of phosphodiestearse-4 improves memory deficits, oxidative stress, neuroinflammation and neuropathological alterations in mouse models of dementia of Alzheimer\u2019s Type. Biomed. Pharmacother. 88, 698\u2013707. https:\/\/doi.org\/10.1016\/j.biopha.2017.01.059 (2017).","journal-title":"Biomed. Pharmacother."},{"key":"98743_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fphar.2017.00237","volume":"8","author":"CR Sims","year":"2017","unstructured":"Sims, C. R. et al. Rolipram improves outcome in a rat model of infant sepsis-induced cardiorenal syndrome. Front. Pharmacol. 8, 237. https:\/\/doi.org\/10.3389\/fphar.2017.00237 (2017).","journal-title":"Front. Pharmacol."},{"key":"98743_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.conb.2007.01.007","volume":"17","author":"S Mackie","year":"2007","unstructured":"Mackie, S., Millar, J. K. & Porteous, D. J. Role of DISC1 in neural development and schizophrenia. Curr. Opin. Neurobiol. 17, 95\u2013102. https:\/\/doi.org\/10.1016\/j.conb.2007.01.007 (2007).","journal-title":"Curr. Opin. Neurobiol."},{"key":"98743_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1741-7015-11-96","volume":"11","author":"N Kumar","year":"2013","unstructured":"Kumar, N., Goldminz, A. M., Kim, N. & Gottlieb, A. B. Phosphodiesterase 4-targeted treatments for autoimmune diseases. BMC Med. 11, 96. https:\/\/doi.org\/10.1186\/1741-7015-11-96 (2013).","journal-title":"BMC Med."},{"key":"98743_CR30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1124\/jpet.114.214155","volume":"350","author":"AR Rutter","year":"2014","unstructured":"Rutter, A. R. et al. GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species. J. Pharmacol. Exp. Ther. 350, 153\u2013163. https:\/\/doi.org\/10.1124\/jpet.114.214155 (2014).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"98743_CR31","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","volume":"58","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer\u2019s disease. J. Med. Chem. 58, 8616\u20138637. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01222 (2015).","journal-title":"J. Med. Chem."},{"key":"98743_CR32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1017\/S1461145711000836","volume":"15","author":"C Wang","year":"2012","unstructured":"Wang, C. et al. The phosphodiesterase-4 inhibitor rolipram reverses Abeta-induced cognitive impairment and neuroinflammatory and apoptotic responses in rats. Int. J. Neuropsychopharmacol. 15, 749\u2013766. https:\/\/doi.org\/10.1017\/S1461145711000836 (2012).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"98743_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.expneurol.2013.03.026","volume":"247","author":"P Kraft","year":"2013","unstructured":"Kraft, P. et al. The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing blood\u2013brain-barrier damage, inflammation and thrombosis. Exp. Neurol. 247, 80\u201390. https:\/\/doi.org\/10.1016\/j.expneurol.2013.03.026 (2013).","journal-title":"Exp. Neurol."},{"key":"98743_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0165-5728(99)00063-6","volume":"97","author":"VA Folcik","year":"1999","unstructured":"Folcik, V. A. et al. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: An additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors. J. Neuroimmunol. 97, 119\u2013128. https:\/\/doi.org\/10.1016\/s0165-5728(99)00063-6 (1999).","journal-title":"J. Neuroimmunol."},{"key":"98743_CR35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.surg.2008.05.017","volume":"144","author":"MT Harting","year":"2008","unstructured":"Harting, M. T., Jimenez, F., Adams, S. D., Mercer, D. W. & Cox, C. S. Jr. Acute, regional inflammatory response after traumatic brain injury: Implications for cellular therapy. Surgery 144, 803\u2013813. https:\/\/doi.org\/10.1016\/j.surg.2008.05.017 (2008).","journal-title":"Surgery"},{"key":"98743_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1161\/STROKEAHA.117.018904","volume":"49","author":"H Ren","year":"2018","unstructured":"Ren, H. et al. Selective NLRP3 (pyrin domain-containing protein 3) inflammasome inhibitor reduces brain injury after intracerebral hemorrhage. Stroke 49, 184\u2013192. https:\/\/doi.org\/10.1161\/STROKEAHA.117.018904 (2018).","journal-title":"Stroke"},{"key":"98743_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fneur.2017.00004","volume":"8","author":"MA Babi","year":"2017","unstructured":"Babi, M. A. & James, M. L. Peri-hemorrhagic edema and secondary hematoma expansion after intracerebral hemorrhage: From benchwork to practical aspects. Front. Neurol. 8, 4. https:\/\/doi.org\/10.3389\/fneur.2017.00004 (2017).","journal-title":"Front. Neurol."},{"key":"98743_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0893-133X(02)00344-5","volume":"27","author":"HT Zhang","year":"2002","unstructured":"Zhang, H. T. et al. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme. Neuropsychopharmacology 27, 587\u2013595. https:\/\/doi.org\/10.1016\/S0893-133X(02)00344-5 (2002).","journal-title":"Neuropsychopharmacology"},{"key":"98743_CR39","doi-asserted-by":"publisher","first-page":"D678","DOI":"10.2741\/skalhegg","volume":"5","author":"BS Skalhegg","year":"2000","unstructured":"Skalhegg, B. S. & Tasken, K. Specificity in the cAMP\/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front. Biosci. 5, D678\u2013D693. https:\/\/doi.org\/10.2741\/skalhegg (2000).","journal-title":"Front. Biosci."},{"key":"98743_CR40","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1007\/s12035-015-9318-8","volume":"53","author":"J Li","year":"2016","unstructured":"Li, J. et al. Minocycline protects against NLRP3 inflammasome-induced inflammation and P53-associated apoptosis in early brain injury after subarachnoid hemorrhage. Mol. Neurobiol. 53, 2668\u20132678. https:\/\/doi.org\/10.1007\/s12035-015-9318-8 (2016).","journal-title":"Mol. Neurobiol."},{"key":"98743_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","volume":"27","author":"E Galkina","year":"2009","unstructured":"Galkina, E. & Ley, K. Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27, 165\u2013197. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132620 (2009).","journal-title":"Annu. Rev. Immunol."},{"key":"98743_CR42","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cell.2012.01.017","volume":"148","author":"SJ Park","year":"2012","unstructured":"Park, S. J. et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148, 421\u2013433. https:\/\/doi.org\/10.1016\/j.cell.2012.01.017 (2012).","journal-title":"Cell"},{"key":"98743_CR43","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.22038\/IJBMS.2017.9272","volume":"20","author":"P Yan","year":"2017","unstructured":"Yan, P. et al. Regulation of autophagy by AMP-activated protein kinase\/sirtuin 1 pathway reduces spinal cord neurons damage. Iran. J. Basic Med. Sci. 20, 1029\u20131036. https:\/\/doi.org\/10.22038\/IJBMS.2017.9272 (2017).","journal-title":"Iran. J. Basic Med. Sci."},{"key":"98743_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.292","volume":"7","author":"XS Zhang","year":"2016","unstructured":"Zhang, X. S. et al. Sirtuin 1 activation protects against early brain injury after experimental subarachnoid hemorrhage in rats. Cell Death Dis. 7, e2416. https:\/\/doi.org\/10.1038\/cddis.2016.292 (2016).","journal-title":"Cell Death Dis."},{"key":"98743_CR45","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s12035-017-0520-8","volume":"55","author":"M Khan","year":"2018","unstructured":"Khan, M., Shah, S. A. & Kim, M. O. 17beta-estradiol via SIRT1\/Acetyl-p53\/NF-kB signaling pathway rescued postnatal rat brain against acute ethanol intoxication. Mol. Neurobiol. 55, 3067\u20133078. https:\/\/doi.org\/10.1007\/s12035-017-0520-8 (2018).","journal-title":"Mol. Neurobiol."},{"key":"98743_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/STROKEAHA.114.006372","volume":"46","author":"Y Zheng","year":"2015","unstructured":"Zheng, Y. et al. 17beta-Estradiol attenuates hematoma expansion through estrogen receptor alpha\/silent information regulator 1\/nuclear factor-kappa b pathway in hyperglycemic intracerebral hemorrhage mice. Stroke 46, 485\u2013491. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006372 (2015).","journal-title":"Stroke"},{"key":"98743_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0014-2999(95)00457-2","volume":"286","author":"RJ Heaslip","year":"1995","unstructured":"Heaslip, R. J. & Evans, D. Y. Emetic, central nervous system, and pulmonary activities of rolipram in the dog. Eur. J. Pharmacol. 286, 281\u2013290. https:\/\/doi.org\/10.1016\/0014-2999(95)00457-2 (1995).","journal-title":"Eur. J. Pharmacol."},{"key":"98743_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neulet.2019.01.026","volume":"699","author":"E Nelissen","year":"2019","unstructured":"Nelissen, E. et al. Validation of the xylazine\/ketamine anesthesia test as a predictor of the emetic potential of pharmacological compounds in rats. Neurosci. Lett. 699, 41\u201346. https:\/\/doi.org\/10.1016\/j.neulet.2019.01.026 (2019).","journal-title":"Neurosci. Lett."},{"key":"98743_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1527-3458.2001.tb00206.x","volume":"7","author":"J Zhu","year":"2001","unstructured":"Zhu, J., Mix, E. & Winblad, B. The antidepressant and antiinflammatory effects of rolipram in the central nervous system. CNS Drug Rev. 7, 387\u2013398. https:\/\/doi.org\/10.1111\/j.1527-3458.2001.tb00206.x (2001).","journal-title":"CNS Drug Rev."},{"key":"98743_CR50","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1096\/fj.201601377RR","volume":"31","author":"M Li","year":"2017","unstructured":"Li, M., Ren, H., Sheth, K. N., Shi, F. D. & Liu, Q. A TSPO ligand attenuates brain injury after intracerebral hemorrhage. FASEB J. 31, 3278\u20133287. https:\/\/doi.org\/10.1096\/fj.201601377RR (2017).","journal-title":"FASEB J."},{"key":"98743_CR51","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cbi.2019.06.008","volume":"308","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y., Shan, Z., Zhao, Y. & Ai, Y. Sevoflurane prevents miR-181a-induced cerebral ischemia\/reperfusion injury. Chem. Biol. Interact. 308, 332\u2013338. https:\/\/doi.org\/10.1016\/j.cbi.2019.06.008 (2019).","journal-title":"Chem. Biol. Interact."},{"key":"98743_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainresbull.2019.10.011","volume":"154","author":"D Luan","year":"2020","unstructured":"Luan, D. et al. MST4 modulates the neuro-inflammatory response by regulating IkappaBalpha signaling pathway and affects the early outcome of experimental ischemic stroke in mice. Brain Res. Bull. 154, 43\u201350. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.10.011 (2020).","journal-title":"Brain Res. Bull."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98743-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98743-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98743-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:08:43Z","timestamp":1670083723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98743-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98743"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98743-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]},"assertion":[{"value":"26 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19737"}}